Navigation Links
GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start.
Date:8/19/2007

ng governments and public health officials around the world effectively respond to the global threat of a flu pandemic and we are pleased to be working with the US government in its preparedness efforts."

Initiation of H5N1 clinical trials

Today also marked the start of the first pre-pandemic vaccine trials involving GSK's proprietary adjuvanted H5N1 vaccine in North America. The vaccine used in these trials will be produced at the company's North American manufacturing facility in Quebec, Canada. These U.S. studies are supported by a contract [HHS100200700029C] from BARDA/ASPR/HHS awarded in January 2007 for the advanced development of antigen-sparing pandemic influenza vaccines towards U.S.-licensure with a commitment to U.S. production of 150 million doses of pandemic vaccine within six months of a pandemic onset.

The trials highlight the company's continuing commitment to its global pre-pandemic influenza vaccine development program. Data from earlier European studies, using a pre-pandemic vaccine produced at GSK's Dresden, Germany facility, showed that the influenza candidate vaccine may be able to induce immune responses that might protect against different strains of H5N1.

GSK's first North American pre-pandemic vaccine trial will be a Phase I/II study that evaluates its H5N1 antigen alone and in combination with one of its proprietary Adjuvant Systems, in 675 subjects. This Phase I/II study is expected to lead into a larger, multi-center, Phase III trial - one of the largest in North America - which is expected to enroll approximately 4,400 subjects later in 2007.

Ripley Ballou, Vice President of Clinical Development for Flu at GlaxoSmithKline said: "The goal of our North American clinical development program is to establish GSK's second manufacturing facility as a source for H5N1 vaccine, further strengthening our efforts to support governments' pandemic preparedness strategies. The initiation of these trials underscores the im
'/>"/>

SOURCE GlaxoSmithKline

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. GlaxoSmithKline and Genmab Present Positive Phase II Results With ofatumumab in Patients With Rheumatoid Arthritis (RA)
2. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
3. New Data on Genmab and GlaxoSmithKlines Ofatumumab: Phase II Study in Rheumatoid Arthritis to be Presented at EULAR
4. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
5. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
6. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
7. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
8. Researchers Discover Gene For Rare Skin Disorder
9. Remarks by President Bush on Stem Cell Veto and Executive Order
10. IMPAX Presents at Movement Disorder Societys 11th International Congress of Parkinsons Disease and Movement Disorders
11. International Movement Disorder Specialists Receive New Information About the Use of Once-Daily Azilect in the Treatment of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 2015 BioClinica®, Inc ., ein ... gab heute bekannt, dass es mit MediciGroup ® ... und Erhalt von Patienten übernommen hat. Der ... Ltd. und Access to Patients, LLC. Medici bietet ... Auffinden von Patienten, die für die Nachbeobachtung verloren ...
(Date:7/7/2015)... , July 7, 2015 The Global ... 1,197.7 million by 2020, growing at an estimated CAGR of ... by Grand View Research, Inc. Introduction of innovative technologies including ... growing awareness levels pertaining to the advantages of breast milk ... six years. In addition, presence of untapped growth opportunities in ...
(Date:7/7/2015)... 7, 2015   Bionik Laboratories Corp. ... with a core focus in robotic exoskeleton technology ... "Company"), announced today that it has completed an ... consisting of its common stock and warrants for ... a private placement transaction.  This equity financing is ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4Bionik Laboratories Completes US$13.1 Million Private Placement 2Bionik Laboratories Completes US$13.1 Million Private Placement 3
... and Methods, ROCKVILLE, Md., June 11 ... company developing,therapeutics for the treatment of cancer and ... No. 7,371,741 covering analogs of 2-,methoxyestradiol (2ME2). The ... property protection through 2025 for analogs,of 2ME2 in ...
... 11 , - Data Published in the ... no Negative Impact on Overall Survival or Tumour,Progression, ... randomised, controlled,studies in 2,301 cancer patients shows that ... impact on survival, tumour,progression or deaths caused by ...
Cached Medicine Technology:EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 2EntreMed Receives New Patent for 2-Methoxyestradiol Analogs 3New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients 2
(Date:7/7/2015)... ... 2015 , ... Today, the physicians at Allied Anesthesia, who provide services to ... Bernardino counties, released a series of tips to help children stay safe over the ... who spend more unsupervised time outdoors. , The most common causes of injuries ...
(Date:7/7/2015)... ... July 07, 2015 , ... WiseWear®, a wearable startup ... first line of luxury smart jewelry called the Socialite™ collection. The product line ... fall. , “The Socialite collection was crafted to inspire women to be ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... growth strategy expert Jay Warden as Senior Vice President, heading the firm’s Healthcare ... to provide the best solutions to healthcare providers’ needs in ways that strengthen ...
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... Refining convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial and ... mobile program, surpassing their original 2015 fundraising goal by nearly $100,000, to ...
(Date:7/7/2015)... ... July 07, 2015 , ... Difass USA, a modern supplement brand committed ... stressful days at work is knowing that there is hopefully a vacation to look ... free as imagined. Planning for a vacation can be quite stressful, and it’s difficult ...
Breaking Medicine News(10 mins):Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 2Health News:Allied Anesthesia Physicians Release Summertime Safety Tips 3Health News:WiseWear Unveils Luxury Smart Jewelry Line 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 2Health News:Difass USA Offers Eight Tips to Help Relax and Enjoy Summer Vacation 3
... Ormond Street Hospital have developed a way of testing the ... known that very young children have a problem in breathing ... function tests. ,The researchers have devised a method ... of five years. The test was presented at the launch ...
... Seven women doctors have been suspended for their alleged ... sting operation beamed yesterday. // ,The doctors ... (Kota), Priyanaka Saxena (Sawaimadhopur), Madhu Mathur (Jhalawar), Rajkumar Choudhary ... on "awaiting posting order" and asked to report to ...
... Sun Pharmaceutical Industries Ltd today said it has allotted 61,716 ... into equity shares by FCCB holders. // ,The ... equity shares of Rs five each of the company at ... FCCBs of 1000 dollar each, the company informed the Bombay ...
... has revealed that only about 50% of the people are ... Mater Hospital in North Dublin. ,Nearly 4 among ... stance that the new hospital comes up at Mater. There ... wrong note, and now the opposition parties have requested the ...
... An analysis of records of pancreatic surgery during the ... by pancreatic cancer surgeon// Charles J. Yeo, M.D., Samuel ... Medical College of Thomas Jefferson University and Thomas Jefferson ... and his colleagues have revealed that contrary to what ...
... intestinal surgery, including stomach reduction for obesity, may increase ... of the study have been published in the British ... on three patients with increasingly poor eyesight or night ... space of a year. None of the patients had ...
Cached Medicine News:Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 2Health News:Pancreatic Cancer Surgery Successful in 80-Year-Olds 3
... The NIDEK YC-1800 is an ... laser delivery and output technologies, improved ... offset and compact design with versatility ... YC-1800 replaces the YC-1600 and adds ...
... have an integrated filter made of ... This filter provides protection against carryover ... it does not swell up as ... can then be recovered easily. In ...
Lightweight PVC housing for easy transport, integrated handle. Easy lamp exchange....
... • V-shaped bottom allows easy ... lips facilitate pour-out ,• Nesting ring ... Solution Basin designed for 4, 8, and ... V-shaped bottom permits withdrawal of practically all ...
Medicine Products: